Received: 18 August 2020
Accepted: 25 November 2020
First Online: 5 January 2021
: Pawel Kalinski has received a Grant from AIM (previously Hemispherx) to support the trial of Ampligen in patients with COVID-19. This latest development occurred after preparation of this manuscript. Rajesh Ramanathan, Haroon Choudry, Heather Jones, Mark Girgis, William Gooding, and David L. Bartlett have no disclosures to declare.
Free to read: This content has been made available to all.